Literature DB >> 21070974

Phosphoinositides are essential coactivators for p21-activated kinase 1.

Todd I Strochlic1, Julien Viaud, Ulrike E E Rennefahrt, Theonie Anastassiadis, Jeffrey R Peterson.   

Abstract

Phospholipid-enriched membranes such as the plasma membrane can serve as direct regulators of kinase signaling. Pak1 is involved in growth factor signaling at the plasma membrane, and its dysregulation is implicated in cancer. Pak1 adopts an autoinhibited conformation that is relieved upon binding to membrane-bound Rho GTPases Rac1 or Cdc42, but whether lipids also regulate Pak1 in vivo is unknown. We show here that phosphoinositides, particularly PIP(2), potentiate Rho-GTPase-mediated Pak1 activity. A positively charged region of Pak1 binds to phosphoinositide-containing membranes, and this interaction is essential for membrane recruitment and activation of Pak1 in response to extracellular signals. Our results highlight an active role for lipids as allosteric regulators of Pak1 and suggest that Pak1 is a "coincidence detector" whose activation depends on GTPases present in phosphoinositide-rich membranes. These findings expand the role of phosphoinositides in kinase signaling and suggest how altered phosphoinositide metabolism may upregulate Pak1 activity in cancer cells.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070974      PMCID: PMC3026281          DOI: 10.1016/j.molcel.2010.10.015

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  29 in total

1.  Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI.

Authors:  G R Hoffman; N Nassar; R A Cerione
Journal:  Cell       Date:  2000-02-04       Impact factor: 41.582

Review 2.  Biology of the p21-activated kinases.

Authors:  Gary M Bokoch
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

Review 3.  A tale of two Paks.

Authors:  Luis E Arias-Romero; Jonathan Chernoff
Journal:  Biol Cell       Date:  2008-02       Impact factor: 4.458

4.  An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently.

Authors:  Julien Viaud; Jeffrey R Peterson
Journal:  Mol Cancer Ther       Date:  2009-09-01       Impact factor: 6.261

5.  Membrane ruffling requires coordination between type Ialpha phosphatidylinositol phosphate kinase and Rac signaling.

Authors:  Renee L Doughman; Ari J Firestone; Michelle L Wojtasiak; Matthew W Bunce; Richard A Anderson
Journal:  J Biol Chem       Date:  2003-04-06       Impact factor: 5.157

6.  A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions.

Authors:  J R Peterson; R S Lokey; T J Mitchison; M W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 7.  PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions.

Authors:  Iman van den Bout; Nullin Divecha
Journal:  J Cell Sci       Date:  2009-11-01       Impact factor: 5.285

8.  Identification of novel membrane-binding domains in multiple yeast Cdc42 effectors.

Authors:  Satoe Takahashi; Peter M Pryciak
Journal:  Mol Biol Cell       Date:  2007-10-03       Impact factor: 4.138

Review 9.  Lipid activation of protein kinases.

Authors:  Alexandra C Newton
Journal:  J Lipid Res       Date:  2008-11-24       Impact factor: 5.922

Review 10.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

View more
  26 in total

1.  PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape.

Authors:  Elizabeth M Morse; Xiaowen Sun; Jordan R Olberding; Byung Hak Ha; Titus J Boggon; David A Calderwood
Journal:  J Cell Sci       Date:  2015-11-23       Impact factor: 5.285

Review 2.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

Review 3.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

Review 4.  Membrane-trafficking sorting hubs: cooperation between PI4P and small GTPases at the trans-Golgi network.

Authors:  Felipe H Santiago-Tirado; Anthony Bretscher
Journal:  Trends Cell Biol       Date:  2011-07-19       Impact factor: 20.808

5.  The Role of the Pleckstrin Homology Domain-containing Protein CKIP-1 in Activation of p21-activated Kinase 1 (PAK1).

Authors:  Yong-Bae Kim; Yong Jae Shin; Adhiraj Roy; Jeong-Ho Kim
Journal:  J Biol Chem       Date:  2015-07-09       Impact factor: 5.157

6.  LAT-independent Erk activation via Bam32-PLC-γ1-Pak1 complexes: GTPase-independent Pak1 activation.

Authors:  Alexandre K Rouquette-Jazdanian; Connie L Sommers; Robert L Kortum; Deborah K Morrison; Lawrence E Samelson
Journal:  Mol Cell       Date:  2012-09-13       Impact factor: 17.970

7.  Synergistic activation of p21-activated kinase 1 by phosphatidylinositol 4,5-bisphosphate and Rho GTPases.

Authors:  Kimberly A Malecka; Zsofia Szentpetery; Jeffrey R Peterson
Journal:  J Biol Chem       Date:  2013-02-07       Impact factor: 5.157

Review 8.  What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway.

Authors:  Samuel J Klempner; Andrea P Myers; Lewis C Cantley
Journal:  Cancer Discov       Date:  2013-11-21       Impact factor: 39.397

9.  Merlin inhibits Wnt/β-catenin signaling by blocking LRP6 phosphorylation.

Authors:  M Kim; S Kim; S-H Lee; W Kim; M-J Sohn; H-S Kim; J Kim; E-H Jho
Journal:  Cell Death Differ       Date:  2016-06-10       Impact factor: 15.828

10.  PAK1 mediates resistance to PI3K inhibition in lymphomas.

Authors:  Katherine Walsh; Matthew S McKinney; Cassandra Love; Qingquan Liu; Alice Fan; Amee Patel; Jason Smith; Anne Beaven; Dereje D Jima; Sandeep S Dave
Journal:  Clin Cancer Res       Date:  2013-01-08       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.